{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:18:00Z","timestamp":1753877880989,"version":"3.41.2"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Sexual function can be negatively influenced by adverse drug reactions (ADRs) potentially caused by &amp;gt;300 drugs. These sexual ADRs (sADRs) can lead to low adherence and decreased quality of life. Physicians are known to barely discuss sexual function. Pharmacists also have an important role in informing and advising patients on ADRs, but it is unknown how community pharmacists deal with sADRs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>The purpose of this study was to evaluate the current practice, attitudes, and knowledge of community pharmacists about informing, detecting, and discussing sADRs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An online survey with 31 questions was sent to all 1932 pharmacy members of the Royal Dutch Pharmacists Association. The survey was modified from previous surveys that questioned different medical disciplines on their practice, attitudes, and knowledge of sexual function related to their fields. Questions were added on pharmacists\u2019 practice concerning ADRs in general.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 97 (5%) pharmacists responded. During first dispenses of drugs, 64 (66%) informed patients on a selection of common ADRs. Almost all (n = 93, 97%) discussed diarrhea or constipation in at least half of the related occasions, whereas 26 to 31 (27%-33%) discussed sADRs. The sADRs for high-risk drugs were more often named at first than at second dispenses (n = 61 [71%] vs n = 28 [32%]). Pharmacy technicians were generally considered not to discuss sADRs (n = 73, 76%; never or in less than half of the occasions). Lack of privacy (n = 54, 57%) and language barriers (n = 45, 47%) were the most acknowledged barriers to discuss sADRs. Moreover, 46% (n = 45) considered their knowledge insufficient to discuss sADRs. Responsibility for informing, advising, and detecting sADRs was most often attributed to pharmacy technicians (n = 59, 62%), pharmacists (n = 46, 48%), and patients (n = 75, 80%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study shows that one-third of pharmacists and two-thirds of pharmacy technicians barely talked about sADRs during first dispenses for high-risk drugs. The low response rate suggests that mostly interested pharmacists responded, thus likely overestimating the sADR discussion rate. To provide patients with unique opportunities to discuss sADRs in community pharmacies, more attention is needed for raising awareness about the topic among pharmacists and for barriers such as the presence of other clients and limited knowledge about sADRs.<\/jats:p><\/jats:sec>","DOI":"10.1093\/sexmed\/qfac014","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T21:09:27Z","timestamp":1673557767000},"source":"Crossref","is-referenced-by-count":0,"title":["First insights into the current practice, knowledge, and attitudes of community pharmacists regarding sexual adverse drug reactions: a cross-sectional survey"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-7601","authenticated-orcid":false,"given":"Rineke","family":"Gordijn","sequence":"first","affiliation":[{"name":"Leiden University Medical Center Department of Clinical Pharmacy and Toxicology, , Leiden, 2300 RC, the \u00a0 Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melianthe P J","family":"Nicolai","sequence":"additional","affiliation":[{"name":"Netherlands Cancer Institute\u2013Antoni van Leeuwenhoek Hospital Department of Urology, , Amsterdam, 1066 CX, the \u00a0 Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk W","family":"Elzevier","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center Department of Urology and Medical Decision Making, , Leiden, 2300 RC, the \u00a0 Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk-Jan","family":"Guchelaar","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center Department of Clinical Pharmacy and Toxicology, , Leiden, 2300 RC, the \u00a0 Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Teichert","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center Department of Clinical Pharmacy and Toxicology, , Leiden, 2300 RC, the \u00a0 Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"issue":"3","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/fampra\/cmaa116","article-title":"An estimation of patients at potential risk for drug-induced sexual dysfunction using pharmacy dispensing data","volume":"38","author":"Gordijn","year":"2021","journal-title":"Fam Pract"},{"issue":"2","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.curtheres.2005.04.006","article-title":"Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey","volume":"66","author":"Ashton","year":"2005","journal-title":"Curr Ther Res Clin Exp"},{"issue":"21","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3109\/09638288.2012.754953","article-title":"Sexuality after stroke: patient counseling preferences","volume":"35","author":"Stein","year":"2013","journal-title":"Disabil Rehabil"},{"issue":"1","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cam4.1239","article-title":"Patient satisfaction with information on oral anticancer agent use","volume":"7","author":"Boons","year":"2018","journal-title":"Cancer Med"},{"issue":"6","key":"2023033116304943400_","first-page":"766","article-title":"Unravelling sexual care in chronically ill patients: the perspective of GP practice nurses","volume":"37","author":"Barnhoorn","year":"2020","journal-title":"Health Service Research Fam Pract"},{"issue":"5","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00392-013-0549-2","article-title":"Discussing sexual function in the cardiology practice","volume":"102","author":"Nicolai","year":"2013","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12875-022-01660-8","article-title":"Let's talk about sex: exploring factors influencing the discussion of sexual health among chronically ill patients in general practice","volume":"23","author":"Barnhoorn","year":"2022","journal-title":"BMC Prim Care"},{"issue":"5","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/13561820.2017.1334635","article-title":"Physicians\u2019 and pharmacists\u2019 information provision and patients' psychological distress","volume":"31","author":"Takaki","year":"2017","journal-title":"J Interprof Care"},{"issue":"4","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ijpp.12522","article-title":"Barriers and facilitators for community pharmacists' participation in pharmacy practice research: a survey","volume":"27","author":"Kuipers","year":"2019","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"2023033116304943400_","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jep.12783","article-title":"Provision of pharmaceutical care by community pharmacists across Europe: is it developing and spreading?","volume":"23","author":"Costa","year":"2017","journal-title":"J Eval Clin Pract"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/11\/1\/qfac014\/49716911\/qfac014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/11\/1\/qfac014\/49716911\/qfac014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T16:50:30Z","timestamp":1701708630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/doi\/10.1093\/sexmed\/qfac014\/6986086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/sexmed\/qfac014","relation":{},"ISSN":["2050-1161"],"issn-type":[{"type":"electronic","value":"2050-1161"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2023,1,12]]},"article-number":"qfac014"}}